| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $216.2M | +12.4% |
| Cost of Revenue | $78.5M | +6.3% |
| Gross Profit | $137.6M | +16.2% |
| R&D Expense | $45.9M | +20.3% |
| SG&A Expense | $27.8M | +18.1% |
| Operating Income | -$5.8M | -198.3% |
| Pre-tax Income | -$5.4M | -209.8% |
| Income Tax | -$1.8M | — |
| Net Income | -$3.7M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.1M | +22.7% |
| Short-term Investments | $2.7M | -76.6% |
| Accounts Receivable | $7.1M | -2.4% |
| Inventory | $26.2M | +89.6% |
| Current Assets | $74.6M | +13.0% |
| Total Assets | $131.0M | +19.9% |
| Current Liabilities | $57.4M | +22.3% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8.8M | +31.8% |
| Capital Expenditures | $5.2M | +24.0% |
| Investing Cash Flow | -$6.1M | -25.8% |
| Financing Cash Flow | $1.8M | +206.7% |
| Free Cash Flow | $3.6M | +45.3% |
| -108.7% |
| EPS (Basic) | -$0.15 | -114.3% |
| EPS (Diluted) | -$0.15 | -114.3% |
| Total Liabilities |
| $67.9M |
| +16.6% |
| Stockholders' Equity | $63.1M | +23.7% |